Trade Commission Finds Mixed Effects From Patents In COVID-19 Fight

A new report from the US International Trade Commission found that patents had a mixed effect on access to diagnostics and therapeutics during the COVID-19 pandemic. Trade group AdvaMed says the findings demonstrate that patent waiver programs aren’t needed for COVID-19 diagnostics. 

Flag flies at the entrance of the US International Trade Commission in Washington, DC.
• Source: Shutterstock

Patents on COVID-19 diagnostics and therapeutics had mixed effects on the global availability of those products, the US International Trade Commission concluded in a recent report.

The 496-page document, which was issued on 17 October, was prepared in response to a request from the US Trade...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Legal & IP

More from Policy & Regulation